A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : 3-MT / 3-methoxytyramine

[Related PubMed/MEDLINE]
Total Number of Papers: 240
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   3-MT  (>> Co-occurring Abbreviation)
Long Form:   3-methoxytyramine
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 A high sensitivity LC-MS/MS method for measurement of 3-methoxytyramine in plasma and associations between 3-methoxytyramine, metanephrines, and dopamine. DA, MN, NMN, RIs
2021 Addition of 3-methoxytyramine or chromogranin A to plasma free metanephrines as the initial test for pheochromocytoma and paraganglioma: Which is the best diagnostic strategy. CgA, CI, MNs
2021 Membrane bound catechol-O-methytransferase is the dominant isoform for dopamine metabolism in PC12 cells and rat brain. ADHD, COMT, DLPFC, DOPAC, HVA, MB-COMT, S-COMT
2021 Polymer Modified Carbon Fiber Microelectrodes for Precision Neurotransmitter Metabolite Measurements. CFMEs, DA, DOPAL, PEDOT, PEI
2021 Structure engineering of lanthanide functionalized metal-organic frameworks: A versatile tool for the early diagnosis of pheochromocytomas and paragangliomas. ---
2021 Study of stability and interference for catecholamines and metanephrines, 3-methoxytyramine: key point of an accurate diagnosis for pheochromocytoma and paraganglioma. DA, EPI, MN, NE, NMN
2020 A 3-min UPLC-MS/MS method for the simultaneous determination of plasma catecholamines and their metabolites: Method verification and diagnostic efficiency. CVs, DA, LLMIs, LODs, MN, NE, NMN, ROC
2020 An LC-MRM assay for the quantification of metanephrines from dried blood spots for the diagnosis of pheochromocytomas and paragangliomas. DBSs, MN, NMN, PITC
2020 Ascorbate deficiency decreases dopamine release in gulo-/- and APP/PSEN1 mice. AD, DA, HVA
10  2020 Blood sampling for metanephrines comparing venipuncture vs. indwelling intravenous cannula in healthy subjects. IQR, MNs, NMN
11  2020 Detection of spot urinary free metanephrines and 3-methoxytyramine with internal reference correction for the diagnosis of pheochromocytomas and paragangliomas. Cr, MN, MNs, NMN
12  2020 Development of a fast liquid chromatography-tandem mass spectrometry method for simultaneous quantification of neurotransmitters in murine microdialysate. 5-HIAA, ACh, Ch, DA, EP, GABA, L-dopa, ME, NE
13  2020 Perinatal exposure to bisphenol A causes a disturbance of neurotransmitter metabolic pathways in female mouse offspring: A focus on the tryptophan and dopamine pathways. 5-HT, BPA, DA, DOPAC, HVA, KYN, Trp
14  2020 Pro-cognitive effect of 1MeTIQ on recognition memory in the ketamine model of schizophrenia in rats: the behavioural and neurochemical effects. 1MeTIQ, NOR
15  2020 Quantitation using HRMS: A new tool for rapid, specific and sensitive determination of catecholamines and deconjugated methanephrines metanephrines in urine. LC-HRMS, LCEC, NorE, NorMN, SPE
16  2020 Stability and reference intervals of spot urinary fractionated metanephrines and methoxytyramine by tandem mass spectrometry as a screening method for pheochromocytoma and paraganglioma. MN, NMN, SPE
17  2020 [Clinical profile of pheochromocytoma and paraganglioma with normal plasma free metanephrines]. CgA, MNs
18  2019 Anxiolytic effect of a novel 9,10-dihydrophenanthrene, juncuenin H, is associated with metabolic changes in cortical serotonin/dopamine levels in mice. 5-HIAA, DA, DOPAC, HVA
19  2019 Dataset on effects of perinatal exposure to propylthiouracil on serum T4, body weight gain, day of eye opening and brain monoamine contents in offspring mice. 5-HIAA, DA, DOPAC, GD, HVA, PND, PTU, TH
20  2019 Development of a PC12 Cell Based Assay for Screening Catechol-O-methyltransferase Inhibitors. COMT, DOPAC, HVA
21  2019 Mechanical allodynia induced by optogenetic sensory nerve excitation activates dopamine signaling and metabolism in medial nucleus accumbens. DA, IMS, mNAc, VTA
22  2019 MicroRNA-326 Inhibits Apoptosis and Promotes Proliferation of Dopaminergic Neurons in Parkinson's Disease Through Suppression of KLK7-Mediated MAPK Signaling Pathway. DA, DOPAC, GSH-Px, HVA, iNOS, KLK7, MAPK, MDA, miRs, PD, SOD, TH
23  2019 Pharmacokinetics of N-ethylpentylone and its effect on increasing levels of dopamine and serotonin in the nucleus accumbens of conscious rats. 5-HIAA, AUC, DA, DOPAC, i.p, MRT, NAc, NEP
24  2019 Plasma free metanephrines for diagnosis of neuroblastoma patients. MN, NB, NMN, PFM
25  2019 Polymer Modified Carbon Fiber-Microelectrodes and Waveform Modifications Enhance Neurotransmitter Metabolite Detection. 5-HIAA, CFMEs, DOPAC, HVA, PEI
26  2019 Validation of an improved liquid chromatography tandem mass spectrometry method for rapid and simultaneous analysis of plasma catecholamine and their metabolites. DA, IS, LOQ, MN, NE, NMN
27  2018 Chronic stress changes prepulse inhibition after amphetamine challenge: the role of the dopaminergic system. CeA, CMS, GABA, NAc, PPI
28  2018 Clinical and biochemical assessment of depressive symptoms in patients with Alkaptonuria before and after two years of treatment with nitisinone. 5-HIAA, AKU, BDI-II
29  2018 Metabolism of Dopamine in Nucleus Accumbens Astrocytes Is Preserved in Aged Mice Exposed to MPTP. DA, ML, MLDA, NSDA, PD
30  2018 Pharmacokinetics, metabolism and safety of deuterated L-DOPA (SD-1077)/carbidopa compared to L-DOPA/carbidopa following single oral dose administration in healthy subjects. 3-OMD, CD, COMT, DA, GMRs, L-DOPA, MAO, PK
31  2017 3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients. EFS, OS
32  2017 Assessment of the Effect of Once Daily Nitisinone Therapy on 24-h Urinary Metadrenalines and 5-Hydroxyindole Acetic Acid Excretion in Patients with Alkaptonuria After 4Weeks of Treatment. MA, NMA
33  2017 Catecholamines profiles at diagnosis: Increased diagnostic sensitivity and correlation with biological and clinical features in neuroblastoma patients. HVA, MIBG, NBL, NMN, VMA
34  2017 Multiple Administration of Endogenous Amines TIQ and 1MeTIQ Protects Against a 6-OHDA-Induced Essential Fall of Dopamine Release in the Rat Striatum: In Vivo Microdialysis Study. 1MeTIQ, PD, TIQs
35  2017 Neurochemical evidence that cocaine- and amphetamine-regulated transcript (CART) 55-102 peptide modulates the dopaminergic reward system by decreasing the dopamine release in the mouse nucleus accumbens. CART, DA, DAQ, DOPAC, DOPAL, DOPET, EFS-evoked, HPLC, HVA, NE
36  2016 Mass spectrometric quantification of salivary metanephrines-A study in healthy subjects. MN, NMN
37  2016 Validated methods for determination of neurotransmitters and metabolites in rodent brain tissue and extracellular fluid by reversed phase UHPLC-MS/MS. 5-HIAA, ACh, DA, ECF, GABA, Glu, HVA, LLOQ, LOD, ME, MRM, NE, NTs
38  2016 Yokukansan, a Traditional Japanese Medicine, Enhances the L-DOPA-Induced Rotational Response in 6-Hydroxydopamine-Lesioned Rats: Possible Inhibition of COMT. AIMs, COMT, DA, L-DOPA, YKS
39  2015 Altered histamine neurotransmission in HPRT-deficient mice. 1-MH, 1-MI4AA, HPLC, HPRT, LNS, MS/MS
40  2015 Deconjugated urinary metanephrine, normetanephrine and 3-methoxytyramine in laboratory diagnosis of pheochromocytoma and paraganglioma. MN, NMN, PGL, PHEO
41  2015 Dopamine concentration in blood platelets is elevated in patients with head and neck paragangliomas. HNPGLs
42  2015 Plasma free metanephrine, normetanephrine, and 3-methoxytyramine for the diagnosis of pheochromocytoma/paraganglioma. HNPGL, MEN2, MN, NF1, NM, PGL, PHEO, VHL
43  2015 Simultaneous analysis of multiple neurotransmitters by hydrophilic interaction liquid chromatography coupled to tandem mass spectrometry. 5-HIAA, GABA, HILIC, L-DOPA
44  2014 A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones as selective monoamine oxidase (MAO) A inhibitors. 5-HIAA, DOPAC, MAO, MAOA
45  2014 Cytotoxic, genotoxic, and neurotoxic effects of Mg, Pb, and Fe on pheochromocytoma (PC-12) cells. DA
46  2014 Ghrelin receptor antagonism of morphine-induced accumbens dopamine release and behavioral stimulation in rats. DOPAC, HVA
47  2014 kappa-opioid receptor as a key mediator in the regulation of appetitive 50-kHz ultrasonic vocalizations. 5-HIAA, MOR, mPFC, NAcc, USVs, VTA
48  2014 Substantial telomere shortening in the substantia nigra of telomerase-deficient mice does not increase susceptibility to MPTP-induced dopamine depletion. PD
49  2013 Plasma levels of free metanephrines and 3-methoxytyramine indicate a higher number of biochemically active HNPGL than 24-h urinary excretion rates of catecholamines and metabolites. HNPGLs, MNs, NMN
50  2013 The effects of sapropterin on urinary monoamine metabolites in phenylketonuria. 5-HIAA, DA, DOPAC, HVA, Phe, PKU
51  2012 Antidepressant-like activity of the endogenous amine, 1-methyl-1,2,3,4-tetrahydroisoquinoline in the behavioral despair test in the rat, and its neurochemical correlates: a comparison with the classical antidepressant, imipramine. 1MeTIQ, 5-HIAA, DOPAC, MAO, MHPG
52  2012 Comparative behavioral and neurochemical studies of R- and S-1-methyl-1,2,3,4-tetrahydroisoquinoline stereoisomers in the rat. 1MeTIQ
53  2012 Effects of 3-O-methyldopa, L-3,4-dihydroxyphenylalanine metabolite, on locomotor activity and dopamine turnover in rats. 3-OMD, COMT, DA, DOPAC, HVA, L-DOPA, PD
54  2012 Simultaneous measurement of serotonin, dopamine and their metabolites in mouse brain extracts by high-performance liquid chromatography with mass spectrometry following derivatization with ethyl chloroformate. DA, HPLC, HVA
55  2012 Synthesis and evaluation of a set of para-substituted 4-phenylpiperidines and 4-phenylpiperazines as monoamine oxidase (MAO) inhibitors. DOPAC, MAO, MAOA
56  2011 Analysis of urinary neurotransmitters by capillary electrophoresis: sensitivity enhancement using field-amplified sample injection and molecular imprinted polymer solid phase extraction. CE, DA, FASI, SPE
57  2011 Important role of 3-methoxytyramine in the inhibition of cocaine sensitization by 1-methyl-1,2,3,4-tetrahydroisoquinoline: an in vivo microdialysis study. 1MeTIQ
58  2010 Binding of dopamine and 3-methoxytyramine as l-DOPA metabolites to human alpha(2)-adrenergic and dopaminergic receptors. DOPAC, HVA, l-DOPA
59  2010 Dopamine excess in patients with head and neck paragangliomas. MIBG, PGL
60  2010 Performance of plasma free metanephrines measured by liquid chromatography-tandem mass spectrometry in the diagnosis of pheochromocytoma. MN, NMN
61  2010 The dopamine metabolite 3-methoxytyramine is a neuromodulator. TAAR1
62  2009 1-Methyl-1,2,3,4-tetrahydroisoquinoline antagonizes a rise in brain dopamine metabolism, glutamate release in frontal cortex and locomotor hyperactivity produced by MK-801 but not the disruptions of prepulse inhibition, and impairment of working memory in rat. 1MeTIQ, DA, DOPAC, HVA, PPI
63  2009 Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors. MNs, NMN
64  2009 Paraquat induces alternation of the dopamine catabolic pathways and glutathione levels in the substantia nigra of mice. DA, DOPAC, HVA, PQ, ROS, SN, SNpc, TH
65  2008 3-Methoxytyramine, an extraneuronal dopamine metabolite plays a physiological role in the brain as an inhibitory regulator of catecholaminergic activity. ---
66  2007 Effects of cyclic hydrostatic pressure on the brain biogenic amines concentrations in the flounder, Platichthys flesus. 5-HIAA, 5-HT, DA, DOPAC, HP, HVA, L-DOPA, NE
67  2005 Central effects of nafadotride, a dopamine D3 receptor antagonist, in rats. Comparison with haloperidol and clozapine. 5-HIAA, 5-HT, DA, DOPAC, HVA, NA
68  2005 Influence of paraquat on dopaminergic transporter in the rat brain. DAT, MPTP
69  2005 Neurotoxic action of 6-hydroxydopamine on the nigrostriatal dopaminergic pathway in rats sensitized with D-amphetamine. 5-HIAA, 5-HT, DA, DOPAC, HVA
70  2004 3-Methoxytyramine as an indicator of dopaminergic manipulation in the equine athlete. DOPAC, HVA
71  2004 Alternating extremely low frequency magnetic field increases turnover of dopamine and serotonin in rat frontal cortex. 5-HIAA, 5-HT, DA, DOPAC, ELF MF, ELF-MF, HVA, NA
72  2004 Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites. 5-HI-3-AA, 5-MI-3-AA, 5-MTP, 5-MTT, DHMA, DOPAC, hOAT1, HVA, MN, NA-5-HTT, NMN, VMA
73  2004 Human brain dopamine metabolism in levodopa-induced dyskinesia and wearing-off. DA, DOPAC, Dysk, HVA, LD, PD, WO
74  2004 The role of noradrenergic and dopaminergic hyperactivity in the development of spontaneous recurrence of methamphetamine psychosis and susceptibility to episode recurrence. MAP, NE
75  2003 Neurotransmitter levels in brains of chronically Jiawey Siwu-treated rats. 5-HIAA, 5-HT, Asp, DA, DOPAC, EPI, GABA, Glu, HVA, JS, NE, VMA
76  2003 Role of the nitric oxide/cyclic GMP pathway and extracellular environment in the nitric oxide donor-induced increase in dopamine secretion from PC12 cells: a microdialysis in vitro study. DA, NO, sGC
77  2002 Factors for susceptibility to episode recurrence in spontaneous recurrence of methamphetamine psychosis. MAP, NE
78  2001 Analysis of S-nitroso-N-acetylpenicillamine effects on dopamine release in the striatum of freely moving rats: role of endogenous ascorbic acid and oxidative stress. DA, DOPAC, HVA, SNAP, SNP
79  2001 Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties. 1BnTIQ, 1MeTIQ, COMT, DOPAC, HVA, MAO
80  2001 Evaluation of specific high-performance liquid-chromatographic determinations of urinary adrenaline and noradrenaline by comparison with isotope dilution mass spectrometry. ECD, GC-MS, MA, NMA
81  2001 Evaluation of specific high-performance liquid-chromatographic determinations of urinary metanephrine and normetanephrine by comparison with isotope dilution mass spectrometry. ECD, GC-MS, MN, NMN
82  2001 Gender-dependent enhanced adult neurotoxic response to methamphetamine following fetal exposure to the drug. DA, HVA
83  2000 Analysis of 3-morpholinosydnonimine and sodium nitroprusside effects on dopamine release in the striatum of freely moving rats: role of nitric oxide, iron and ascorbic acid. DA, DOPAC, HVA, L-DOPA, SNP
84  2000 Behavioral and mesocorticolimbic dopamine responses to non aggressive social interactions depend on previous social experiences and on the opponent's sex. DA, NAS, OT, PFC
85  2000 Effects of dopamine metabolites on locomotor activities and on the binding of dopamine: relevance to the side effects of L-dopa. CA, COMT, DA, DIMPEA, MAT, NM, PD, TD
86  1999 Effects of morphine on metabolism of dopamine and serotonin in brains of alcohol-preferring AA and alcohol-avoiding ANA rats. ---
87  1999 Effects of the administration of amphetamine, either alone or in combination with reserpine or cocaine, on regional brain beta-phenylethylamine and dopamine release. AMPH, DA, PEA
88  1999 Postmortem instability of dopamine and its metabolites in rat striatum and limbic forebrain. DA, DOPAC, HPLC, HVA
89  1999 The involvement of noradrenergic transmission in the morphine-induced locomotor hyperactivity in mice withdrawn from repeated morphine treatment. DA, DOPAC, HVA, MOPEG, NA
90  1998 Chronic verapamil modifies striatal and frontal cortex dopamine levels. 5-HIAA, DA, DOPAC, HVA
91  1998 Conditioned place preference induced by a combination of L-dopa and a COMT inhibitor, entacapone, in rats. COMT, CPP, DA, HVA
92  1998 Cross-sensitization between footshock stress and apomorphine on self-injurious behavior and neostriatal catecholamines in a rat model of Lesch-Nyhan syndrome. APO, DA, LNS, NE, SB, SIB
93  1998 Effects of taltirelin hydrate (TA-0910), a novel thyrotropin-releasing hormone analog, on in vivo dopamine release and turnover in rat brain. 5-HIAA, 5-HTP, DA, DOPA, DOPAC, HVA, MHPG, TRH
94  1998 Effects of thyroid hormone on catecholamine and its metabolite concentrations in rat cardiac muscle and cerebral cortex. CA, DA, DOPAC, HVA, MN, NE, NMN
95  1997 Aroclor 1254-induced alterations in hypothalamic monoamine metabolism in the Atlantic croaker (Micropogonias undulatas): correlation with pituitary gonadotropin release. 5-HIAA, DA, HVA, LHRHa, MPH, NE, POAH
96  1997 Effects of allopurinol on striatal dopamine, ascorbate and uric acid during an acute morphine challenge: ex vivo and in vivo studies. AA, DA, DHAA, DOPAC, HVA, ROS, UA
97  1997 Effects of single and repeated footshock on dopamine release and metabolism in the brains of Fischer rats. DOPAC, HVA
98  1997 [Monoamines, monoamine metabolites, neuron specific enolase and myelin basic protein concentrations in cerebrospinal fluid of resuscitated patients]. 5-HIAA, BD, DOPAC, HVA, MBP, MHPG, MN, NMN, NSE, PVS, VA, VMA
99  1996 Concurrent locomotor stimulation and decrease in dopamine release in rats and mice after treatment with the competitive NMDA receptor antagonists D-CPPene and CGS 19755. DA, NMDA
100  1996 Effects of morphine treatment and withdrawal on striatal and limbic monoaminergic activity and ascorbic acid oxidation in the rat. 5-HIAA, 5-HT, AA, DA, DHAA, DOPAC, GABA, HPLC, HVA